MESALAZINE ASSOCIATED NEPHROGENIC DIABETES-INSIPIDUS PRESENTING AS WEIGHT-LOSS

被引：37

作者：

MASSON, EA ^{[1
]}

RHODES, JM ^{[1
]}

机构：

[1] WALTON HOSP,LIVERPOOL L9 1AE,MERSEYSIDE,ENGLAND

来源：

GUT | 1992年 / 33卷 / 04期

关键词：

D O I：

10.1136/gut.33.4.563

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Nephrotoxicity in association with 5-aminosalicylic acid therapy is well recognised. In this patient the nephrotoxicity only became apparent after severe weight loss had occurred in association with nephrogenic diabetes insipidus. The patient aged 26 with ulcerative colitis received resin coated mesalazine (Asacol) 1200 mg/day and lost 12 kg in weight over a four month period, only complaining of thirst towards the end of this period.

引用

收藏

页码：563 / 564

页数：2

相关论文

共 11 条

[1] NEPHROTIC SYNDROME ASSOCIATED WITH SULFASALAZINE [J].

BARBOUR, VM ;

WILLIAMS, PF .

BRITISH MEDICAL JOURNAL, 1990, 301 (6755) :818-818

[2]

CAMERON JS, 1988, Q J MED, V66, P97

[3]

CRISTENSEN LA, 1990, ALIMENT PHARM THERAP, V4, P523

[4] COMPARISON OF THE ABSORPTION AND METABOLISM OF SULPHASALAZINE AND ACRYLIC-COATED 5-AMINO SALICYLIC-ACID IN NORMAL SUBJECTS AND PATIENTS WITH COLITIS [J].

DEW, MJ ;

EBDEN, P ;

KIDWAI, NS ;

LEE, G ;

EVANS, BK ;

RHODES, J .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (04) :474-476

[5] COLONIC RELEASE OF 5-AMINO SALICYLIC-ACID FROM AN ORAL PREPARATION IN ACTIVE ULCERATIVE-COLITIS [J].

DEW, MJ ;

RYDER, REJ ;

EVANS, N ;

EVANS, BK ;

RHODES, J .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (02) :185-187

[6]

DEW MJ, 1990, INFLAMMATORY BOWEL D, P365

[7] SULFASALAZINE IN ULCERATIVE-COLITIS - IN MEMORIAM [J].

HAYLLAR, J ;

BJARNASON, I .

GUT, 1991, 32 (05) :462-463

[8] DISPOSITION OF 5-AMINOSALICYLIC ACID BY OLSALAZINE AND 3 MESALAZINE PREPARATIONS IN PATIENTS WITH ULCERATIVE-COLITIS - COMPARISON OF INTRALUMINAL COLONIC CONCENTRATIONS, SERUM VALUES, AND URINARY-EXCRETION [J].

LAURSEN, LS ;

STOKHOLM, M ;

BUKHAVE, K ;

RASKMADSEN, J ;

LAURITSEN, K .

GUT, 1990, 31 (11) :1271-1276

[9]

MEHTA RP, 1990, CAN MED ASSOC J, V143, P1031

[10]

NORVIS BH, 1990, BRIT MED J, V296, P1442